drugset / Trial / NCT00584246
Pregabalin (Lyrica) for the Treatment of Restless Legs Syndrome
RandomizedParallel-groupTriple-blindTreatment
Summary
This study will evaluate the safety and efficacy of Pregabalin (Lyrica) in treating patients with Restless Legs Syndrome (RLS) in a double-blind, placebo-controlled trial.
Timeline
- Start
- 2007-11
- Primary completion
- 2008-05
- Completion
- 2008-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Pregabalin | Small molecule | 50 mg | Oral |
| Subject | Pregabalin | Small molecule | 150 mg | Oral |